NOV 23, 2019 11:20 PM PST

Can artificial intelligence increase tuberculosis drug development?

WRITTEN BY: Nouran Amin

It’s no secret that there is a shortage of tuberculosis drug development. To combat this issue, researchers at the University of Michigan designed a predicative software tool for drug candidates that can serve as an effective treatment. The tool is referred to as ‘INDIGO’ short for INferring Drug Interactions using chemoGenomics and Orthology.

Tuberculosis is the world’s most fatal bacterial infection killing roughly 1.8 million people annually.

Learn more about tuberculosis, the world’s deadliest bacterial infection:

“This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, who leads the research.

INDIGO has shown that tuberculosis drugs (Bedaquiline, Clofazimine, Rifampicin, Clarithromycin) can be potent when paired with antipsychotics like ‘thioridazine’ or antimalarials drugs, for example ‘P218’.

The findings of the study were published in mBio.

“This tool can accurately predict the activity of drug combinations, including synergy—where the activity of the combination is greater than the sum of the individual drugs,” said Shuyi Ma, a research scientist at the University of Washington and a first author of the study. “It also accurately predicts antagonism between drugs, where the activity of the combination is lesser. In addition, it also identifies the genes that control these drug responses.”

“Successful combinations identified by INDIGO, when tested in a lab setting, showed synergy 88.8% of the time,” Chandrasekaran said.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 26, 2021
Cell & Molecular Biology
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
MAR 26, 2021
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
For the many people waiting for transplants, 3D-printed organs can't come soon enough. Researchers have been making stri ...
MAR 30, 2021
Clinical & Molecular DX
The COVID Eye of the Tiger
MAR 30, 2021
The COVID Eye of the Tiger
A wearable COVID screening device that uses light sensors to check for signs of infection has gotten FDA regulatory clea ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 12, 2021
Technology
HubSpot and Modern Health Partner to Support Mental Wellbeing in the Workplace
JUN 12, 2021
HubSpot and Modern Health Partner to Support Mental Wellbeing in the Workplace
The hardships of 2020 exposed many flaws in our social and economic systems, including the ways we address mental health ...
JUL 09, 2021
Cell & Molecular Biology
Wearable Tech for...Plants?
JUL 09, 2021
Wearable Tech for...Plants?
Researchers have developed a "wearable" patch to detect the gaseous substances plants emit when diseased or stressed,
JUL 27, 2021
Technology
First Prescription Digital Therapeutic Expands Access to Mental Health Care
JUL 27, 2021
First Prescription Digital Therapeutic Expands Access to Mental Health Care
Treatment for disorders like depression and anxiety usually requires regular visits to a psychiatrist or, at the very le ...
Loading Comments...